Figure 3
(A) LFS was investigated for AML patients according to risk score of the three-gene signature. (B) OS was investigated for AML patients according to risk score of the three-gene signature.
Low-risk group predicts favorable prognosis in AML

(A) LFS was investigated for AML patients according to risk score of the three-gene signature. (B) OS was investigated for AML patients according to risk score of the three-gene signature.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept